Suppr超能文献

荧光恶性疟原虫的体外生长抑制测定法的建立。

Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays.

机构信息

Infection and Immunity Division, the Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria, 3050, Australia.

出版信息

Malar J. 2010 Jun 3;9:152. doi: 10.1186/1475-2875-9-152.

Abstract

BACKGROUND

Plasmodium falciparum in vitro growth inhibition assays are widely used to evaluate and quantify the functional activity of acquired and vaccine-induced antibodies and the anti-malarial activity of known drugs and novel compounds. However, several constraints have limited the use of these assays in large-scale population studies, vaccine trials and compound screening for drug discovery and development.

METHODS

The D10 P. falciparum line was transfected to express green fluorescent protein (GFP). In vitro growth inhibition assays were performed over one or two cycles of P. falciparum asexual replication using inhibitory polyclonal antibodies raised in rabbits, an inhibitory monoclonal antibody, human serum samples, and anti-malarials. Parasitaemia was evaluated by microscopy and flow cytometry.

RESULTS

Transfected parasites expressed GFP throughout all asexual stages and were clearly detectable by flow cytometry and fluorescence microscopy. Measurement of parasite growth inhibition was the same when determined by detection of GFP fluorescence or staining with ethidium bromide. There was no difference in the inhibitory activity of samples when tested against the transfected parasites compared to the parental line. The level of fluorescence of GFP-expressing parasites increased throughout the course of asexual development. Among ring-stages, GFP-fluorescent parasites were readily separated from uninfected erythrocytes by flow cytometry, whereas this was less clear using ethidium bromide staining. Inhibition by serum and antibody samples was consistently higher when tested over two cycles of growth compared to one, and when using a 1 in 10 sample dilution compared to 1 in 20, but there was no difference detected when using a different starting parasitaemia to set-up growth assays. Flow cytometry based measurements of parasitaemia proved more reproducible than microscopy counts.

CONCLUSIONS

Flow cytometry based assays using GFP-fluorescent parasites proved sensitive and highly reproducible for quantifying the growth-inhibitory activity of antibodies and anti-malarials, with superior reproducibility to light microscopy, and are suitable for high-throughput applications.

摘要

背景

恶性疟原虫体外生长抑制试验广泛用于评估和量化获得性和疫苗诱导的抗体的功能活性,以及已知药物和新型化合物的抗疟活性。然而,在大规模人群研究、疫苗试验和化合物筛选用于药物发现和开发方面,这些检测存在一些限制。

方法

将 D10 恶性疟原虫系转染以表达绿色荧光蛋白(GFP)。使用在兔中产生的抑制性多克隆抗体、抑制性单克隆抗体、人血清样本和抗疟药物进行一次或两次恶性疟原虫无性繁殖周期的体外生长抑制试验。通过显微镜和流式细胞术评估寄生虫血症。

结果

转染的寄生虫在所有无性阶段都表达 GFP,通过流式细胞术和荧光显微镜清晰可检测。通过检测 GFP 荧光或用溴化乙锭染色来确定寄生虫生长抑制的结果相同。与亲本系相比,用转染的寄生虫检测时,样本的抑制活性没有差异。GFP 表达寄生虫的荧光强度在无性发育过程中逐渐增加。在环期,GFP 荧光寄生虫通过流式细胞术很容易与未感染的红细胞分离,而用溴化乙锭染色则不太清楚。与一次循环生长相比,两次循环生长时血清和抗体样本的抑制活性更高,与 1:20 稀释相比,1:10 稀释时更高,但当使用不同的起始寄生虫血症来设置生长试验时,没有检测到差异。基于流式细胞术的寄生虫血症测量比显微镜计数更具可重复性。

结论

使用 GFP 荧光寄生虫的基于流式细胞术的检测方法对定量抗体和抗疟药物的生长抑制活性非常敏感且具有高度可重复性,与光镜相比具有更高的重现性,适用于高通量应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dde9/2891815/e9328ccdc447/1475-2875-9-152-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验